Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.
Published by: INSEAD
Originally published in: 2003
Version: October 2003
Notes: To maximise their effectiveness, colour items should be printed in colour.

Abstract

The objective of this teaching case is to place students in the complex moral and legal environment of AIDS in South Africa. During the 1990s, South Africa, along with many other developing countries, agreed to accept World Trade Organisation disciplines with respect to trade in intellectual property - the so-called TRIPS agreement. In 1997, however, the South African Government passed a new Medicines Act, which a group of pharmaceutical companies argued was in violation of South African patent laws and of the TRIPS accord. The lawsuit was quickly attacked by such leading non-governmental organisations as Oxfam. This case forces students to address pharmaceutical company policy in the face of the AIDS pandemic.
Location:
Industry:
Other setting(s):
Late 1990s to early 2000s

About

Abstract

The objective of this teaching case is to place students in the complex moral and legal environment of AIDS in South Africa. During the 1990s, South Africa, along with many other developing countries, agreed to accept World Trade Organisation disciplines with respect to trade in intellectual property - the so-called TRIPS agreement. In 1997, however, the South African Government passed a new Medicines Act, which a group of pharmaceutical companies argued was in violation of South African patent laws and of the TRIPS accord. The lawsuit was quickly attacked by such leading non-governmental organisations as Oxfam. This case forces students to address pharmaceutical company policy in the face of the AIDS pandemic.

Settings

Location:
Industry:
Other setting(s):
Late 1990s to early 2000s

Related